May 13, 2009 (FinancialWire) — CareFusion Corp., a company that is slated become publicly-traded spinoff of Cardinal Health’s (NYSE: CAH) clinical and medical products businesses, has named Edward J. Borkowski as its chief financial officer.

Borkowski has been CFO of Mylan since 2002. During his tenure at Mylan, the company closed its $7 billion acquisition of Merck Generics in 2007. Borkowski also played a role in Mylan’s acquisition of India-based Matrix Laboratories in 2006. He will start with CareFusion on May 26.

Cardinal Health said its target is to complete the planned spinoff later this summer.

San Diego-based CareFusion is expected by Cardinal to have annual revenues approaching $4 billion.

The company develops technologies including IV pumps, automated dispensing and patient identification systems, electronic infection surveillance service, ventilation and respiratory products, pulmonary products, infection prevention products and surgical instruments.

CareFusion employs more than 15,000 people across its global operations.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.